Q4 Results today: Aurobindo Pharma, Reliance Power, Divi’s Laboratories, and Paras Defence and Space Technologies will…
Tag: Aurobindo Pharma
Nifty Pharma hits record; GlaxoSmith, Aurobindo Pharma touch 52-week high
On Monday’s trading session, Nifty Pharma touched a record high at 15,950.80 level, up 0.9%. Among…
Aurobindo Pharma, other pharma stocks rise up to 94% this year. Here’s why
Stocks such as Glenmark Pharma have surged 94 per cent this year so far while Aurobindo…
Aurobindo Pharma, CreditAccess among top midcap & smallcap gainers last week
However, BSE Sensex touched a fresh record high of 63,601.71 on June 22, while Nifty remained…
FMCG best performer for FPI in FY23, IT companies least preferred
Mumbai : In a year marred by volatility, foreign portfolio investors (FPIs) invested in FMCG stocks,…
Aurobindo Pharma’s Q2 net profit down 41% at Rs 409 crore
Shares of the pharmaceutical company closed at Rs 488 on the BSE on Friday. Hyderabad: Aurobindo…
Aurobindo Pharma net profit down 41% on lower revenues, intense competition
Total revenue from operations at ₹5,739.3 crore (₹5,941.9 crore) was down 3.4% during the quarter Total…
video | Delhi Liquor Policy Case: Head of Hyderabad-based top pharma firm arrested
The Enforcement Directorate has arrested a top official of a pharma company in connection with a…
Aurobindo Pharma Q1 net plunges 32% to ₹520 cr.
Drugmaker Aurobindo Pharma reported a more than 32% decline in consolidated net profit to ₹520.3 crore…